Brief: Next Science Sees Unaudited Product Sales For 2Q To Be Above $5.6M
29/06/2023 02:22
June 29 (Reuters) - Next Science Ltd NXS.AX :
* UNAUDITED PRODUCT SALES FOR 2QFY23 ARE EXPECTED TO BE
ABOVE
US$5.6M
* NEXT SCIENCE IS ON TRACK TO SUBSTANTIALLY EXCEED PRODUCT
SALES
IN 1HFY22 AND 2HFY22
Source text for Eikon: ID:nASXf5Zfs
Further company coverage: NXS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Next Science
See all newsBrief: ASX Says Next Science Limited Will Be Removed From Official List
Brief: Next Science Says CEO & Managing Director I.V. Hall, and CFO Marc Zimmerman Resigned
Brief: Next Science Releases Quarterly Activity Report
Australia's Next Science surges on sale of assets for $50 million
Brief: Next Science To Sell Majority Of Assets